Herpes Simplex Oncolytic Viral Therapy for Malignant Glioma and Mechanisms of Delivery

被引：0
|
作者：
Erickson, Nicholas J. [1 ]
Stavarache, Mihaela [2 ]
Tekedereli, Ibrahim [1 ]
Kaplitt, Michael G. [2 ]
Markert, James M. [1 ]
机构：
[1] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35294 USA
[2] Weill Cornell Med, Dept Neurol Surg, Lab Mol Neurosurg, New York, NY USA
来源：
WORLD NEUROSURGERY | 2025年 / 194卷
关键词：
Magnetic resonance-guided focused ultrasound; Magnetic Malignant glioma; Oncolytic viral therapy; INTENSITY FOCUSED ULTRASOUND; BRAIN-BARRIER DISRUPTION; LIPOSOMAL DOXORUBICIN; RIBONUCLEOTIDE REDUCTASE; GLIOBLASTOMA-MULTIFORME; ENHANCED DELIVERY; TUMOR BARRIER; VIRUS; REPLICATION; VIROTHERAPY;
D O I：
10.1016/j.wneu.2024.123595
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The authors present a comprehensive review on the history and development of oncolytic herpes simplex viral therapies for malignant glioma with a focus on mechanisms of delivery in prior and ongoing clinical trials. This review highlights the advancements made with regard to delivering these therapies to a highly complex immunologic environment in the setting of the blood-brain and blood-tumor barrier in a safe and effective manner.
引用
收藏
页数：9
相关论文
共 50 条
  • [41] ONCOLYTIC VIRAL THERAPY IS FEASIBLE IN DIFFUSE INTRINSIC PONTINE GLIOMA
    Perez-Larraya, Gallego J.
    Garcia-Moure, M.
    Labiano, S.
    Patino-Garcia, A.
    Dobbs, J.
    Gonzalez-Huarriz, M.
    CANCER DISCOVERY, 2022, 12 (09) : 2012 - 2012
  • [42] Oncolytic herpes simplex virus and immunotherapy
    Ma, Wenqing
    He, Hongbin
    Wang, Hongmei
    BMC IMMUNOLOGY, 2018, 19
  • [43] Oncolytic virus therapy using genetically engineered herpes simplex viruses
    Todo, Tomoki
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 2060 - 2064
  • [44] Effective therapy of metastatic ovarian cancer with an oncolytic herpes simplex virus incorporating two membrane fusion mechanisms
    Nakamori, M
    Fu, XP
    Meng, F
    Jin, AW
    Tao, LH
    Bast, RC
    Zhang, XL
    CLINICAL CANCER RESEARCH, 2003, 9 (07) : 2727 - 2733
  • [45] Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry
    Akhtar, Jihan
    Shukla, Deepak
    FEBS JOURNAL, 2009, 276 (24) : 7228 - 7236
  • [46] CHARACTERIZATION OF THE IMMUNE RESPONSE TO ONCOLYTIC ADENOVIRUS THERAPY FOR MALIGNANT GLIOMA
    Kleijn, Anne
    Kloezeman, Jenneke
    Treffers-Westerlaken, Elike
    Fulci, Giulia
    Leenstra, Sieger
    Dirven, Clemens
    Debets, Reno
    Lamfers, Martine
    NEURO-ONCOLOGY, 2011, 13 : 32 - 32
  • [47] Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication
    Aghi, M
    Rabkin, S
    Martuza, RL
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (01): : 38 - 50
  • [48] Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus
    Antoszczyk, Slawomir
    Spyra, Melanie
    Mautner, Victor Felix
    Kurtz, Andreas
    Stemmer-Rachamimov, Anat O.
    Martuza, Robert L.
    Rabkin, Samuel D.
    NEURO-ONCOLOGY, 2014, 16 (08) : 1057 - 1066
  • [49] Oncolytic Virus Targeted Therapy for Glioma via Intravenous Delivery
    He, Yechenxing
    Li, Wei
    Zhang, Xiaowei
    Cui, Zongqiang
    ADVANCED HEALTHCARE MATERIALS, 2025, 14 (07)
  • [50] Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
    Kardani, Kimia
    Gil, Judit Sanchez
    Rabkin, Samuel D.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
12345